制备和评估班达甲基β-β-环德林包括复合物
Yili Ding1,2, Zhiyuan Zhang3, Charles Ding4
1College of Science, Mathematics and Technology, Wenzhou-Kean University, Wenzhou, 325060, P. R. China. yding@kean.edu.
BMC veterinary research
|May 20, 2024
概括
芬班达是一种杀虫剂,具有抗癌潜力,但具有不良的溶性. 一种新型的甲基-β-环氧氨酸纳入复合物显著提高了其水溶性和生物可用性,用于潜在的癌症治疗.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物运输 药物运输 药物运输
- 在瘤学瘤学.
背景情况:
- 班达是一种口服有效的津醇杀虫剂,具有已证明的抗癌性质.
- 它的临床应用受到水溶性差 (0.3μg/mL) 的限制,无法满足药物输送要求 (5-10 mg/mL).
研究的目的:
- 提高班达的水溶性和生物可用性,用于潜在的抗癌应用.
- 为改善药物输送开发一种班达-甲基-β-环氧化综合体.
主要方法:
- 利用单因子和直角策略来制备班达-甲基-β-环德的含有复合物.
- 通过差分扫描热度计,扫描电子显微镜和NMR光谱学来描述复杂的结构.
- 评估了开发的复合体的体外和体内药理动力学概况.
主要成果:
- 实现了班达的纳入复合体,含有29.2%的纳入率和89.5%的纳入收益率.
- 班达的水溶性增加到20.21 mg/mL,明显超过所需的值.
- 证明了快速的体外释放 (在15分钟内释放75%),并在体内提高了班达及其代谢物 (oxfendazole) 的生物可用性138-169%.
结论:
- 班达-甲基-β-环极含复合物在克服可溶性限制方面取得了重大进展.
- 增强的溶解度和生物可用性表明可能减少剂量和提高治疗疗效.
- 这种复合物充满希望,作为一种可行的抗癌药物输送和治疗的有效药物.
更多相关视频
相关概念视频
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:30Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...